FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tetracycline 10 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tetracycline 10 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 3
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength numerator value False 1 Inferred relationship Some 1
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Estradiol 1.04 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 3
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Tetracycline 10 mg/mL cutaneous lotion Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tetracycline 10 mg/mL cutaneous lotion Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Rimantadine hydrochloride 10 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Rimantadine hydrochloride 10 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 3
    Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Estradiol 1.56 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Betamethasone 120 microgram/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Betamethasone 120 microgram/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Diprophylline 10.7 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Diprophylline 10.7 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Progesterone 100 mg vaginal tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Progesterone 100 mg vaginal tablet Count of base of active ingredient False 1 Inferred relationship Some
    Terbutaline sulfate 200 microgram/mL solution for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Terbutaline sulfate 200 microgram/mL solution for inhalation Has concentration strength denominator value False 1 Inferred relationship Some 1
    Theophylline 5.33 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Theophylline 5.33 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 2
    Olopatadine hydrochloride 665 microgram/actuation nasal spray Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 3
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Betamethasone 500 microgram orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Betamethasone 500 microgram orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Promazine 2.5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Promazine 2.5 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 188 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start